Yahoo Web Search

Search results

1. • 

     2 No-Brainer Dividend Stocks to Buy in May

     Motley Fool via Yahoo Finance· 6 days ago

     Which dividend stocks are... giant AT&T (NYSE: T) and pharmaceutical titan Pfizer (NYSE: PFE) scan as incredible bargains for long-term,...

2. • Investing in Pfizer Inc.

     Knox Daily· 2 days ago

     In the deal valued at $26.47 per share,3,000 shares were bought. As a result of this transaction...shares worth roughly $0.25 million. Argus downgraded ...

3. • 

     7 Cheap Value Stocks to Buy Now: May 2024

     InvestorPlace· 4 hours ago

     The major stock market indexes are near record highs. The good news, however, is that investors can still put money to work in today’s market without...

4. • 

     Is Novavax Stock A Buy After Nearly Tripling On $1.3 Billion Sanofi Deal?

     Investor's Business Daily· 23 hours ago

     Shares now have a top Relative Strength Rating of 99. The RS Rating pits all stocks, regardless of...

5. • 

     This 6% Yielding Dividend Stock Could Pump Up Your Passive-Income Stream

     Motley Fool via Yahoo Finance· 6 days ago

     s more than enough to meet a dividend commitment currently set at $1.68 per share annually. In the...

6. • Pfizer Inc's Dividend Analysis

     Guru Focus· 7 days ago

     Pfizer Inc (PFE, Financial) recently announced a dividend of $0.42 per share, payable on 2024-06-14, with the ex-dividend date set for ...

7. • 

     Top Stock Reports for Amazon.com, Visa & Pfizer

     Zacks via Yahoo Finance· 5 days ago

     Marietta (MLM), Weather Woes Ail Per the Zacks analyst, robust infrastructure demand, efficient implementation of SOAR... analyst is impressed with...

8. • 

     One stock is dragging down the S&P 500's earnings growth

     Yahoo Finance via AOL· 2 days ago

     Pfizer (PFE) and Gilead Sciences (GILD). Gilead Sciences reported a loss per share of $1.32 in the...

9. • Unveiling Viatris (VTRS)'s Value: Is It Really Priced Right? A C

     Guru Focus· 13 hours ago

     With a Loss Per Share of 0.06, the question arises: is Viatris modestly overvalued? This article delves into a detailed valuation analysis...make informed ...

10. • 

      Second Death - Pfizer Reports Young Boy's Death After One Year Of Gene Therapy Treatment In Muscle...

      Benzinga via Yahoo Finance· 7 days ago

      A young patient died due to cardiac arrest after receiving Pfizer Inc’s (NYSE:PFE) experimental gene...